Inflation rebates to reduce Medicare payment for 34 Part B drugs

This October through December under the Inflation Reduction Act, Medicare will reduce the beneficiary coinsurance amount for 34 Part B prescription drugs between $1 and $618 per average dose, the Centers for Medicare & Medicaid Services announced recently.

A primer on Medicare Part D prescription drug rebates: Insights

Issue Brief: The Big Government Socialism Bill Jeopardizes the

The Inflation Reduction Act: A tale of two drugs - Putnam

News Academic Progression

How will the Inflation Reduction Act affect Medicare enrollees

Mitigating the Inflation Reduction Act's Adverse Impacts on the

Special Report: Inflation Reduction Act Sets Part D Stakeholders

News ASHRM

Prescription Drugs: Spending, Use, and Prices

Mitigating the Inflation Reduction Act's Adverse Impacts on the

Special Report: Inflation Reduction Act Sets Part D Stakeholders

Medicare price negotiation and pharmaceutical innovation following

Inflation Reduction Act: Adjustments to medication pricing

Inflation Reduction Act Likely To Have A Negative Financial Impact

Comments to CMS Guidance on the Medicare Prescription Drug